Invesco Ltd. - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 71 filers reported holding CHEMOCENTRYX INC in Q1 2015. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q3 2022$42,625,000
-0.1%
825,103
-52.1%
0.01%
+7.7%
Q2 2022$42,651,000
+5.6%
1,721,194
+6.8%
0.01%
+30.0%
Q1 2022$40,388,000
-8.9%
1,610,991
+32.2%
0.01%
-9.1%
Q4 2021$44,355,000
+146.3%
1,218,188
+15.7%
0.01%
+120.0%
Q3 2021$18,012,000
+102.0%
1,053,324
+58.2%
0.01%
+150.0%
Q2 2021$8,918,000
-74.3%
666,013
-1.6%
0.00%
-77.8%
Q1 2021$34,691,000
-42.4%
677,040
-30.4%
0.01%
-50.0%
Q4 2020$60,229,000
+56.9%
972,683
+38.9%
0.02%
+38.5%
Q3 2020$38,378,000
+216.5%
700,333
+232.3%
0.01%
+225.0%
Q2 2020$12,127,000
-4.6%
210,743
-33.4%
0.00%
-20.0%
Q1 2020$12,706,000
+98.3%
316,233
+95.2%
0.01%
+150.0%
Q4 2019$6,406,000
+526.8%
161,968
+7.5%
0.00%
Q3 2019$1,022,000
-32.0%
150,611
-6.9%
0.00%
Q2 2019$1,504,000
-27.3%
161,723
+8.5%
0.00%
-100.0%
Q1 2019$2,070,000
+31.8%
148,988
+3.6%
0.00%0.0%
Q4 2018$1,570,000
-8.8%
143,834
+5.7%
0.00%0.0%
Q3 2018$1,721,000
+232.9%
136,127
+246.5%
0.00%
Q2 2018$517,000
-22.8%
39,282
-20.3%
0.00%
Q1 2018$670,000
+45.0%
49,265
-36.6%
0.00%
Q4 2017$462,000
-46.2%
77,660
-32.9%
0.00%
Q3 2017$859,000
-17.1%
115,762
+4.6%
0.00%
Q2 2017$1,036,000
-41.9%
110,692
-54.8%
0.00%
-100.0%
Q1 2017$1,784,000
-1.5%
245,048
+0.1%
0.00%0.0%
Q4 2016$1,811,000
+522.3%
244,782
+408.6%
0.00%
Q3 2016$291,000
+5720.0%
48,131
+7601.0%
0.00%
Q2 2015$5,000
-93.8%
625
-94.1%
0.00%
Q1 2015$80,00010,5870.00%
Other shareholders
CHEMOCENTRYX INC shareholders Q1 2015
NameSharesValueWeighting ↓
Tri Locum Partners LP 436,300$15,886,0006.25%
TANG CAPITAL MANAGEMENT LLC 500,000$18,205,0003.66%
Integral Health Asset Management, LLC 200,000$7,282,0002.02%
Sofinnova Investments, Inc. 731,222$26,624,0001.56%
Lisanti Capital Growth, LLC 231,035$8,412,0001.22%
Darwin Global Management, Ltd. 161,802$5,891,0000.90%
Cormorant Asset Management, LP 400,000$14,564,0000.87%
Perceptive Advisors 2,830,892$103,072,0000.80%
Avidity Partners Management LP 644,400$23,463,0000.50%
Eventide Asset Management 1,040,000$37,866,0000.48%
View complete list of CHEMOCENTRYX INC shareholders